ATF3 suppresses expression of the enzyme cholesterol 25-hydroxylase (CH25H), which in turn promotes trogocytosis between CTLs and tumor cells, leading to T-cell dysfunction and tumor progression. Here, ATF3 is linked to neoplasm.